Dentsply Sirona Grows Margins Amid Slump

Dentsply Sirona(NASDAQ:XRAY) reported Q2 2025 earnings on August 7, 2025, posting net sales of $936 million (non-GAAP), down 4.9% year-over-year and 6.7% in constant currency and adjusted EPS of $0.52 (up 6.6% YoY). Management maintained full-year sales and EPS guidance, highlighted a 360 basis point year-over-year expansion in adjusted EBITDA margin (non-GAAP) to 21.1%, and outlined planned investments in customer experience, operational efficiency, and innovation under new leadership. The following distills three pivotal earnings call insights shaping the long-term investment thesis.Adjusted EBITDA margin (non-GAAP) rose to 21.1%, up 360 basis points year-over-year, mainly due to cost reductions and the suspension of unprofitable Byte sales, even as sales declined. Operating cash flow was $48 million, down from $208 million in Q2 2024, driven by timing issues and increased inventory prior to ERP system launches.Margin discipline provided sufficient buffer to preserve bottom-line growth in a stagnant demand environment, but the durability of these gains is at risk from tariffs with an annualized run-rate of $80 million, though the actual impact for FY2025 is expected to be $25 million, roughly spread across Q3 and Q4, pressuring future profitability unless further mitigations are successfully implemented.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool